# Safety and Immunogenicity Study of Eastern Equine Encephalitis (EEE) Vaccine

> **NCT00584805** · PHASE2 · COMPLETED · sponsor: **U.S. Army Medical Research and Development Command** · enrollment: 138 (actual)

## Conditions studied

- Eastern Equine Encephalitis

## Interventions

- **BIOLOGICAL:** Inactivated, Dried, TSI-GSD 104, EEE

## Key facts

- **NCT ID:** NCT00584805
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06-03
- **Primary completion:** 2016-06-27
- **Final completion:** 2017-06
- **Target enrollment:** 138 (ACTUAL)
- **Last updated:** 2019-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00584805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00584805, "Safety and Immunogenicity Study of Eastern Equine Encephalitis (EEE) Vaccine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00584805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*